These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

901 related items for PubMed ID: 14573751

  • 1. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT, Yen ML, Lin CY, Kuo ML.
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E.
    J Cell Biol; 2003 May 26; 161(4):793-804. PubMed ID: 12771128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
    Ha CH, Bennett AM, Jin ZG.
    J Biol Chem; 2008 Mar 14; 283(11):7261-70. PubMed ID: 18180305
    [Abstract] [Full Text] [Related]

  • 9. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 14; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 14; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of Csk to VE-cadherin and inhibition of cell proliferation.
    Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D.
    EMBO J; 2005 May 04; 24(9):1686-95. PubMed ID: 15861137
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S, Takagi H, Otani A, Suzuma K, Nishimura K, Honda Y.
    Br J Pharmacol; 1999 May 04; 127(2):537-45. PubMed ID: 10385256
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T.
    Eur J Pharmacol; 2009 May 21; 610(1-3):61-7. PubMed ID: 19374835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.